80 related articles for article (PubMed ID: 11182072)
1. Effects of antiprogestins RU486 and ZK98299 on the expression of cell cycle proteins of a medroxyprogesterone acetate (MPA)-induced murine mammary tumor.
Peters MG; Vanzulli S; Elizalde PV; Charreau EH; Goin MM
Oncol Rep; 2001; 8(2):445-9. PubMed ID: 11182072
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
3. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
6. Expression of G1 phase regulators in MG-63 osteosarcoma cell line.
Merli M; Benassi MS; Gamberi G; Ragazzini P; Sollazzo MR; Molendini L; Magagnoli G; Ferrari C; Maltarello MC; Picci P
Int J Oncol; 1999 Jun; 14(6):1117-21. PubMed ID: 10339667
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stress reduces podocyte proliferation in vitro.
Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
[TBL] [Abstract][Full Text] [Related]
9. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
[TBL] [Abstract][Full Text] [Related]
10. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats.
Jiang W; Zhu Z; Thompson HJ
Cancer Res; 2003 Mar; 63(6):1228-34. PubMed ID: 12649181
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
12. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
Brugarolas J; Bronson RT; Jacks T
J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
Matsuoka M; Tani K; Asano S
Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
[TBL] [Abstract][Full Text] [Related]
15. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Hupfeld CJ; Weiss RH
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
[TBL] [Abstract][Full Text] [Related]
16. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma.
Ito K; Sasano H; Yoshida Y; Sato S; Yajima A
Anticancer Res; 1998; 18(3A):1661-4. PubMed ID: 9673386
[TBL] [Abstract][Full Text] [Related]
18. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
